BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease Post author: Post published: January 11, 2024 Post category:uncategorized The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). You Might Also Like USC-led study advances understanding of prostate cancer genetics in Black men November 5, 2025 CAR T therapy induces remission in multiple autoimmune diseases April 9, 2026 Antioxidant gel preserves islet function after pancreas removal June 7, 2024